{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T13:46:40Z","timestamp":1766065600140},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,1,1]]},"DOI":"10.1215\/s1152851703000334","type":"journal-article","created":{"date-parts":[[2004,5,10]],"date-time":"2004-05-10T22:16:47Z","timestamp":1084227407000},"page":"63-64","source":"Crossref","is-referenced-by-count":53,"title":["Durable response of breast cancer leptomeningeal metastasis to\ncapecitabine monotherapy"],"prefix":"10.1093","volume":"6","author":[{"given":"Lisa R.","family":"Rogers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra E.","family":"Remer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheela","family":"Tejwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,1,1]]},"reference":[{"key":"key\n\t\t\t\t20171013145427_","doi-asserted-by":"crossref","unstructured":"Boogerd, W., Hart, A.A.M., van der Sande, J.J., and Engelsman, E.\n(1991) Meningeal carcinomatosis in breast cancer: Prognostic\nfactors and influence of treatment. Cancer67,1685\n-1695.","DOI":"10.1097\/00000421-200108000-00026"},{"key":"key\n\t\t\t\t20171013145427_","doi-asserted-by":"crossref","unstructured":"Chamberlain, M.C. (1992) Current concepts in\nleptomeningeal metastasis. Curr. Opin. Oncol.4, 533-539.","DOI":"10.1097\/00000421-200108000-00026"},{"key":"key\n\t\t\t\t20171013145427_","doi-asserted-by":"crossref","unstructured":"Grossman, S.A., and Krabak, M.J. (1999) Leptomeningeal\ncarcinomatosis. Cancer Treat. Rev.25,103\n-119.","DOI":"10.1097\/00000421-200108000-00026"},{"key":"key\n\t\t\t\t20171013145427_","doi-asserted-by":"crossref","unstructured":"Heier, M.S., Heintz, R., and Fossa, S.D. (1986)\nPassage of 5\u2032-dFUrd and its metabolites 5-FU and 5-FUH2 to CSF in a\nclinical phase 1 study. Acta Neurol. Scand.74,240\n-244.","DOI":"10.1097\/00000421-200108000-00026"},{"key":"key\n\t\t\t\t20171013145427_","doi-asserted-by":"crossref","unstructured":"Jaeckle, K.A., Phuphanich, S., van den Bent, M.J., Aiken, R.,\nBatchelor, T., Campbell, T., Fulton, D., Gilbert, M., Heros, D., Rogers, L.,\nO'Day, S.J., Akerley, W., Allen, J., Baidas, S., Gertler, S.Z., Greenberg,\nH.S., LaFol lette, S., Lesser, G., Mason, W., Recht, L., Wong, E.,\nChamberlain, M.C., Cohn, A., Glantz, M.J., Gutheil, J.C., Maria, B., Moots,\nP., New, P., Rus sell, C., Shapiro, W., Swinnen, L., and Howell, S.B.\n(2001) Intrathecal treatment of neoplastic meningitis due to\nbreast cancer with a slow-release formulation of cytarabine. Br. J.\nCancer84,157\n-163.","DOI":"10.1097\/00000421-200108000-00026"},{"key":"key\n\t\t\t\t20171013145427_","doi-asserted-by":"crossref","unstructured":"McEvoy, G.K. (Ed.) (2002) Capecitabine. In:\nAHFS Drug Information. Bethesda, MD: American Society\nof Health-System Pharmacists, Inc., pp.916\n-921.","DOI":"10.1097\/00000421-200108000-00026"},{"key":"key\n\t\t\t\t20171013145427_","doi-asserted-by":"crossref","unstructured":"Siegal T. (1998) Leptomeningeal metastases: Rationale\nfor systemic chemotherapy or what is the role of intra-CSF-chemotherapy?\nJ. Neuro oncol.38,151\n-157.","DOI":"10.1097\/00000421-200108000-00026"},{"key":"key\n\t\t\t\t20171013145427_","doi-asserted-by":"crossref","unstructured":"Wang, M.L., Yung, W.K., Royce, M.E., Schomer, D.F., and Theriault,\nR.L. (2001) Capecitabine for 5-fluorouracil-resistant brain\nmetastases from breast cancer. Am. J. Clin. Oncol.24,421\n-424.","DOI":"10.1097\/00000421-200108000-00026"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/6\/1\/63\/13066052\/10_NO6.1Rogers.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T18:54:44Z","timestamp":1507920884000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article\/6\/1\/63\/1146980\/Durable-response-of-breast-cancer-leptomeningeal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,1]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,1,1]]},"published-print":{"date-parts":[[2004,1,1]]}},"URL":"https:\/\/doi.org\/10.1215\/s1152851703000334","relation":{},"ISSN":["1523-5866","1522-8517"],"issn-type":[{"value":"1523-5866","type":"electronic"},{"value":"1522-8517","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,1]]},"published":{"date-parts":[[2004,1,1]]}}}